About the Authors
- Martin Koppitz
-
Affiliation Department for Children and Adolescents, Division for Allergology, Pneumology and Cystic Fibrosis, University Hospital Goethe University, Frankfurt am Main, Germany
- Charlotte Eschenburg
-
Affiliation Department for Children and Adolescents, Division for Allergology, Pneumology and Cystic Fibrosis, University Hospital Goethe University, Frankfurt am Main, Germany
- Emilia Salzmann
-
Affiliation Department for Children and Adolescents, Division for Stem Cell Transplantation and Immunology, University Hospital Goethe University, Frankfurt am Main, Germany
- Martin Rosewich
-
Affiliation Department for Children and Adolescents, Division for Allergology, Pneumology and Cystic Fibrosis, University Hospital Goethe University, Frankfurt am Main, Germany
- Ralf Schubert
-
Affiliation Department for Children and Adolescents, Division for Allergology, Pneumology and Cystic Fibrosis, University Hospital Goethe University, Frankfurt am Main, Germany
- Stefan Zielen
-
* E-mail: Stefan.Zielen@kgu.de
Affiliation Department for Children and Adolescents, Division for Allergology, Pneumology and Cystic Fibrosis, University Hospital Goethe University, Frankfurt am Main, Germany
Competing Interests
The authors of this manuscript have the following competing interests: Stefan Zielen received fees for lectures and advisory boards from the following companies: bene-Arzneimittel GmbH (http://www.bene-arzneimittel.de), Vifor Pharma Deutschland GmbH (http://www.viforpharma.de), Novartis AG (https://www.novartis.com), GlaxoSmithKline GmbH (http://www.glaxosmithkline.de), ALK-Abelló Arzneimittel GmbH (http://www.alk-abello.com), Allergy Therapeutics (http://www.allergytherapeutics.com), Boehringer Ingelheim (https://www.boehringer-ingelheim.de), Allergopharma GmbH (https://www.allergopharma.de) and Biotest (https://www.biotest.com). Martin Rosewich received fees for lectures from the following companies: Novartis AG (https://www.novartis.com), GlaxoSmithKline (http://www.glaxosmithkline.de), Allergopharma GmbH (https://www.allergopharma.de) and Allergy Therapeutics (http://www.allergytherapeutics.com). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RS SZ. Performed the experiments: MK CE RS. Analyzed the data: MK ES MR RS SZ. Contributed reagents/materials/analysis tools: ES RS. Wrote the paper: MK CE ES MR RS SZ.